ScholarIQanswers from OpenAlex

5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease

PaperCitations, authors & open-access status

5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease is a paper indexed in ScholarIQ from OpenAlex.

How many citations does 5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease have?

ScholarIQcitation count

5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease has 122 citations in the OpenAlex counts ScholarIQ stores.

When was 5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease published?

ScholarIQyear

5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease has 2007 year in the ScholarIQ index.

What is the open-access status of 5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease?

ScholarIQoa status

5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease has closed oa status in the ScholarIQ index.

What is the DOI of 5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease?

ScholarIQdoi

The DOI for 5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease is on the source record.

What is the PMID of 5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease?

ScholarIQpmid

The PMID for 5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease is on the source record.

What is the OpenAlex record for 5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease?

ScholarIQopenalex

The OpenAlex for 5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial